NeuroSearch A/S
Notice convening Extraordinary General Meeting in NeuroSearch A/S

NeuroSearch A/S 

15.11.2013 09:46
---------------------------------------------------------------------------

Announcement
15.11.2013



In accordance with Articles 9 and 11 of the Articles of Association, notice is
hereby given of an Extraordinary General Meeting in NeuroSearch A/S to be held
on 


                      Monday, 9 December 2013 at 3 pm (CET)
                                        

at Kromann Reumert, Sundkrogsgade 5, DK-2100 Copenhagen Ø, Denmark with the
following agenda: 


  1. The Board of Directors proposes that the objects of the company in Article
     2 of the Articles of Association is widened; including listing investments
     as part of the objects of the company.
  2. The Board of Directors proposes that Article 5 of the Articles of
     Association is updated as specified in the enclosed draft of the Articles
     of Association. Furthermore, the Board of Directors proposes that Article 8
     on cancellation of share certificates is deleted. Articles 4d and 4f on
     issued warrants will be deleted as they have both expired.
  3. The Board of Directors proposes that Article 18 of the Articles of
     Association on powers to bind the company is amended so that the company
     will be bound by the joint signatures of a member of the Board of Directors
     and a manager or two members of the Board of Directors.
  4. The Board of Directors proposes that Karin Garre is elected to the Board of
     Directors as Torbjörn Bjerke has notified the Board of Directors that he
     wishes to resign.
     
     Karin Garre was born in 1957, she is a Medical Doctor and she has more than
     20 years of wide executive experience from the pharmaceutical industry.
     Karin Garre has previously held positions as Chief Development Officer and
     Executive Vice President in NeuroSearch A/S. Furthermore, Karin Garre is
     Executive Head of Psychiatric Center of Copenhagen.
     
     The Board of Directors intends to elect Karin Garre as its chairman.
  5. Any other business.

Voting requirements
Adoption of the proposals referred to in items 1, 2 and 3 regarding amendments
to the Articles of Association, requires a special majority, cf. Article 14 of
the Articles of Association. Pursuant to Article 14, the adoption of such
proposals requires the affirmative votes of at least two-thirds of the votes
cast as well as at least two-thirds of the votes represented at the
Extraordinary General Meeting. 

Adoption by the general meeting of item 4 of the agenda concerning the election
of a new member of the Board of Directors requires simple majority, cf. Article
14 of the Articles of Association. 

Share capital and voting rights
The share capital of NeuroSearch A/S is nominally DKK 24,553,947 divided into
24,553,947 shares of DKK 1 each. Each share of DKK 1 shall carry 20 votes. 

Registration date
A shareholder's right to participate in the Extraordinary General Meeting and
to cast votes is determined in accordance with the number of shares held by
such shareholder on Monday 2 December 2013 (the record date). The shares held
by each shareholder are determined on the record date on the basis of the
shareholdings registered in the share register and in accordance with any
notices on shareholdings received, but not yet registered, by the company in
the share register. 

Deadline for notice of attendance
In accordance with Article 13 of the Articles of Association, a shareholder
wishing to attend the Extraordinary General Meeting must order an admission
card via the company's website www.neurosearch.com or with NeuroSearch A/S,
Strandvejen 60, DK-2900 Hellerup, Anita Milland (telephone: +45 4460 8000 or
email: ns@neurosearch.com) or with VP Investor Services A/S, Weidekampsgade 14,
P.O. Box 4040, DK-2300 Copenhagen S (telephone: +45 4358 8866 or +45 4358 8893
or email: vpinvestor@vp.dk) no later than Thursday 5 December 2013. 

Proxy
Shareholders who are prevented from attending the Extraordinary General Meeting
may give proxy to the Board of Directors or a third party directly at
www.neurosearch.com. A proxy form can also be printed from the website
(www.neurosearch.com) or it may be requested with NeuroSearch A/S. Please
return the proxy form, duly signed and dated, to VP Investor Services A/S for
receipt no later than Thursday 5 December 2013. 

Postal vote
Shareholders may also submit their vote by post. A voting paper to be used for
postal vote can be printed from the website (www.neurosearch.com) or it may be
requested with NeuroSearch A/S. Please return the voting paper to VP Investor
Services A/S for receipt no later than Thursday 5 December 2013. Once a postal
vote has been received by VP Investor Services A/S, it cannot be revoked by the
shareholder. 

Agenda, etc.
The following information will be made available for the shareholders at the
company's website www.neurosearch.com no later than three weeks before the
Extraordinary General Meeting: 


A) This notice which convenes the Extraordinary General Meeting and includes
the agenda, the full text of the proposals, information about the total number
of shares and voting rights at the date of the notice 


B) The form to be used for voting by proxy and by post


Right to enquire
At the Extraordinary General Meeting, the management will answer questions from
the shareholders on matters of relevance to the company's position and
questions relating to the agenda. 


The Board of Directors


Contact
Allan Andersen, Chairman of the Board of Directors, telephone: +45 4016 3864.


About NeuroSearch
NeuroSearch A/S (NEUR) is listed on NASDAQ OMX Copenhagen A/S.
News Source: NASDAQ OMX



15.11.2013 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      NeuroSearch A/S
              
               
              Denmark
Phone:        
Fax:          
E-mail:       
Internet:     
ISIN:         DK0010224666
WKN:          
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------